Contineum Therapeutics, Inc.

Derivative exercise · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

insider.option_exercise

Occurred

2026-07-08

Reported

2026-07-10

Disclosure lag

2 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Contineum Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	0001628280-26-047909
Event ID	#2440

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001628280-26-047909",
  "acquired_disposed": "A",
  "code": "M",
  "direct_or_indirect": "D",
  "form": "4",
  "is_derivative": false,
  "issuer_name": "Contineum Therapeutics, Inc.",
  "label": "Exercise of derivative",
  "person_name": "Lorrain Daniel S.",
  "price": 1.01,
  "role": "Chief Scientific Officer",
  "security": "Class A Common Stock",
  "shares": 1015,
  "shares_owned_after": 136217,
  "source_path": "edgar/data/1855175/0001628280-26-047909.txt",
  "ticker": "CTNM",
  "value": 1025.15
}

Source: Open recorded SEC filing

Source: SEC EDGAR · as of 2026-07-10T00:00:00Z